BioSpace News Archive

The Lung Cancer Research Foundation announces its newest board chair, Colleen Conner Ziegler.

Regenerex Pharma, Inc., announces the establishment of its comprehensive management team and the commencement of the Company manufacturing plans in Q4 2023.

Brenus Pharma announces that pre-clinical advancements of its inaugural research program were presented at the 7th CICON (International Cancer Immunotherapy) Conference in Milan, Italy (September 20-23) and will be showcased at the 38th Annual SITC (Society for Immunotherapy of Cancer) Congress in San Diego, CA, USA (November 1-5).

ProofPilot announced today a strategic collaboration with global pharmaceutical leader Eli Lilly and Company (Lilly) to offer Lilly’s patent-pending, sensor cloud platform, Magnol.AI™, a state-of-the-art platform that enables sophisticated management of high-frequency sensor data with security and ease, as part of ProofPilot’s technology solution.

Syneos Health, Inc. announced the completion of its acquisition by a consortium of private investment firm affiliates composed of Elliott Investment Management L.P., Patient Square Capital and Veritas Capital.

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that The Journal of the American Medical Association (JAMA) published positive results from the Phase 3 NEURO-TTRansform study of eplontersen, an investigational treatment for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN).

Vyant Bio, Inc., announced that its special meeting of stockholders on September 28, 2023 was reconvened and then adjourned, without conducting any business, in order to provide stockholders additional time within which to vote on the proposals as described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on August 16, 2023.

Pfizer Canada ULC and BioNTech SE announced that Health Canada has authorized the companies’ Omicron XBB.1.5-adapted monovalent COVID-19 vaccine for ages 6 months and older.

INVO Bioscience, Inc., a healthcare services fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture procedure it enables, reminds its shareholders to vote ahead of the upcoming special meeting of shareholders to be held on September 29, 2023 at 12:00 pm.

Rancho Biosciences, the leading Data Science Service company, will be presenting expanded Data Science Services including our LLM work and a new product, Data Crawler that allows scientists to self-serve and find data sets they are looking for easily and quickly.